Welcome to our dedicated page for TERADYNE SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TERADYNE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TERADYNE's regulatory disclosures and financial reporting.
Teradyne, Inc. (TER) filed a Form 144 indicating that shareholder Mercedes Johnson plans to sell up to 625 common shares through Fidelity Brokerage on or after 08/05/2025. At the latest reported market price, the sale would total roughly $66,250. The shares originated from a 05/09/2024 restricted-stock vesting transaction and were received as compensation.
Johnson has already sold 1,875 shares for $198,243.75 during the past three months. The proposed sale represents 0.0004 % of TER’s 159,073,532 shares outstanding, suggesting minimal dilution or trading-volume impact. No material adverse information was reported, and the signer affirms compliance with Rule 10b5-1 and other SEC requirements.
Teradyne (TER) Form 4 highlights a modest insider trade. On 07/30/2025 director Mercedes Johnson sold 1,875 shares of common stock at $105.73 per share under a pre-arranged Rule 10b5-1 plan adopted 02/03/2025, realizing about $0.2 million in gross proceeds.
After the sale, Johnson directly owns 11,988 shares and indirectly owns 1,876 shares via The Mercedes Johnson Trust, bringing total beneficial ownership to 13,864 shares. No derivative securities were involved. The indirect position reflects a 06/05/2025 transfer to her trust that was exempt from reporting under Rule 16a-13. The filing shows no other transactions and appears routine.
Teradyne President & CEO Gregory S. Smith filed a Form 4 reporting the sale of 554 common shares on 30 Jul 2025 at an average price of $105.73, yielding proceeds of roughly $58 k. The trade was executed under a Rule 10b5-1 plan adopted 4 Feb 2025, signalling it was pre-scheduled rather than opportunistic.
Following the transaction, Smith directly owns 97,546.995 shares, which already include 98.7673 shares purchased via the Employee Stock Purchase Plan on 30 Jun 2025. No derivative security activity was reported.
The sale represents about 0.6 % of his direct holdings and is immaterial relative to Teradyne’s total shares outstanding, suggesting limited market impact. No additional insider transactions or corporate events were disclosed in this filing.